NEXGEL, INC. Other Depreciation and Amortization
NEXGEL, INC. (NXGL) reported Other Depreciation and Amortization of $49.00 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherDepreciationAndAmortization · last filed 2022-08-10
- NEXGEL, INC. other depreciation and amortization for the quarter ending 2022-06-30 was $24.00K, a 4.00% decline year-over-year.
- NEXGEL, INC. other depreciation and amortization for the quarter ending 2022-03-31 was $25.00K, a 4.17% increase year-over-year.
- NEXGEL, INC. other depreciation and amortization for the quarter ending 2021-12-31 was $24.00K, a 118.18% increase year-over-year.
- NEXGEL, INC. other depreciation and amortization for the quarter ending 2021-09-30 was $26.00K.
- NEXGEL, INC. other depreciation and amortization for fiscal 2021 was $99.00K, a 135.71% increase from fiscal 2020.
- NEXGEL, INC. other depreciation and amortization for fiscal 2020 was $42.00K.
| Period end | Other Depreciation and Amortization 3 month | Other Depreciation and Amortization 6 month | Other Depreciation and Amortization 9 month | Other Depreciation and Amortization 12 month |
|---|---|---|---|---|
| 2022-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $49.00K 10-Q · filed 2022-08-10 | $73.00K derived: sum of 3 quarters · filed 2022-08-10 | $99.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2022-03-31 | $25.00K 10-Q · filed 2022-05-13 | $49.00K derived: sum of 2 quarters · filed 2022-05-13 | $75.00K derived: sum of 3 quarters · filed 2022-05-13 | $100.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $50.00K derived: sum of 2 quarters · filed 2022-03-21 | $75.00K derived: sum of 3 quarters · filed 2022-08-10 | $99.00K 10-K · filed 2022-03-21 |
| 2021-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $51.00K derived: sum of 2 quarters · filed 2022-08-10 | $75.00K 10-Q · filed 2021-11-10 | $86.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $49.00K 10-Q · filed 2022-08-10 | $60.00K derived: sum of 3 quarters · filed 2022-08-10 | |
| 2021-03-31 | $24.00K 10-Q · filed 2022-05-13 | $35.00K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $42.00K 10-K · filed 2022-03-21 | ||
| 2020-09-30 | $31.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |